Skip to content

Effect of Abhaya Ghrita and Panchabhautika Taila Nasya in treating Autism Spectrum Disorders in children.

Therapeutic efficacy of Abhaya Ghrita and Panchabhautika Taila Nasya in the management of Autism Spectrum Disorders in children - A single arm open label clinical trial.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2018/06/014379
Enrollment
30
Registered
2018-06-01
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Autism Spectrum Disorders

Interventions

Intervention1: 1. ABHAYA GHRITA 2. PANCHABHAUTIKA TAILA: ABHAYA GHRITA 3-6 gm (3-6 yrs) BD oral for 12 weeks 6-9 gm (6-9 yrs) BD oral for 12 weeks 9-12 gm (9-12 yrs)BD oral for 12 weeks Panchabhautik

Sponsors

All India Institute of Ayurveda
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Children between 3-12 years of age with clinical features of Autism Spectrum Disorder using INCLEN Scale. Parents / Guardian willing to give informed written consent to participate in the study.

Exclusion criteria

Exclusion criteria: Children not fulfilling the screening criteria for diagnosis of ASD. Children with chronic ailments like tuberculosis, malignancy, juvenile Diabetes mellitus and other such chronic systemic illness. Children taking anti-epileptic and anti-psychotic drugs.

Design outcomes

Primary

MeasureTime frame
Reduction in the clinical features of Autism Spectrum Disorders assessed by Aberrant Behavior Checklist- Community (ABC-C)Timepoint: Baseline 0 day and End of treatment duration 90 day

Secondary

MeasureTime frame
Changes in the severity of disease using Clinical Global Impression Scale. Changes in the quality of life of Parents using HRQL Scale.Timepoint: 12 weeks

Countries

India

Contacts

Public ContactDr Rajagopala S

All India Institut of Ayurveda

ak_ayu@yahoo.co.in8800543828

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026